The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
CMS Launches Aggressive Crackdown on New York Social Adult Day Care Fraud on October 22, 2026 Posted by
The Silent Epidemic: Stroke Rates Surge Among Younger Adults, Challenging Traditional Medical Wisdom on October 22, 2026 Posted by
The Battle for Bodily Autonomy: Idaho’s High-Stakes Referendum on Abortion Rights on October 22, 2026 Posted by
The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
Posted in Sleep Health Beyond the Prescription: Bridging the Gap Between Clinical Care and Lived Experience in Narcolepsy on September 11, 2026
Posted in Sleep Health A New Dawn in Sleep Medicine: The Global Rollout of Oreporexton Marks a Paradigm Shift in Narcolepsy Type 1 Care on September 9, 2026
Posted in Sleep Health FDA Accepts New Drug Application for AXS-12: A Potential Breakthrough for Narcolepsy-Associated Cataplexy on September 7, 2026
Posted in Sleep Health A New Era in Narcolepsy Care: Evaluating the Impact and Value of Oveporexton on September 6, 2026
Posted in Sleep Health A New Frontier in Sleep Medicine: Promising Phase 2 Results for Alixorexton in Narcolepsy Type 1 on September 4, 2026
Posted in Sleep Health Beyond the Prescription: Bridging the Gap Between Clinical Care and Lived Experience in Narcolepsy on September 4, 2026
Posted in Sleep Health Decoding Narcolepsy: New Research Differentiates Diagnostic Reliability in NT1 and NT2 on September 3, 2026
Posted in Sleep Health A Paradigm Shift in Sleep Medicine: FDA Approves Orzeyful (oveporexton) for Narcolepsy Type 1 on August 31, 2026
Posted in Sleep Health Unlocking the Brain’s "Sleep Brake": A Breakthrough in Understanding Narcolepsy on August 31, 2026
Posted in Sleep Health FDA Greenlights Axsome Therapeutics’ Application for Narcolepsy Treatment AXS-12 on August 30, 2026
